We would like to thank Dr Ichimasa and colleagues for their comments on our recent publication reporting the 3-year ...

Background Effect of glycaemic control on pancreatic cancer (PC) development in patients with long-standing type 2 diabetes ...

Recent advances in high-throughput microbiome profiling have generated expansive data sets that offer unprecedented ...

Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide, largely due to the limited efficacy of ...

We read with great interest the article by Hamada et al1, which provides important insights into the real-world adoption of lumen-apposing metal stents (LAMS) for pancreatic fluid collections (PFCs).

Correspondence to Dr Matthew Kurien, Division of Clinical Medicine, School of Medicine & Population Health, The University of Sheffield Faculty of Medicine Dentistry and Health, Sheffield, South ...

We read with interest the commentary by Camilleri and Talley on whether gastroparesis and functional dyspepsia (FD) are ‘really ‘interchangeable’ diseases’. 1 Their significant efforts to improve the ...

Objective Pancreatic ductal adenocarcinoma (PDA) is characterised by stromal desmoplasia and vascular dysfunction, which critically impair drug delivery. This study examines the role of an abundant ...

Background: Identification of patients at risk for mortality early in the course of acute pancreatitis (AP) is an important step in improving outcome. Methods: Using Classification and Regression Tree ...

Background The polarization of M1 macrophage facilitates steatotic liver graft injury and is regulated by metabolic reprogramming. We previously demonstrated that compromised PGC1α signaling mediated ...

Background Lumen-apposing metal stents (LAMSs) are increasingly used for the endoscopic management of pancreatic fluid collections (PFCs), including walled-off necrosis (WON) and pancreatic ...